You are here
Home > Conditions > Psychotic Disorders > Schizophrenia

Blood Test Helps Diagnosis of Schizophrenia

This post originally featured on PsychCentral. Investigators have developed a blood test that could help doctors more quickly diagnose schizophrenia and other disorders. Researchers from the University of Maryland College Park (UMD) and Baltimore (UMB) campuses believe the new technique will help clinicians and improve patient outcomes. “We hope our new technique will

CBT Shown to Ease Psychotic Symptoms Over Years

This post originally featured on Psychcentral. Cognitive-behavioral therapy (CBT) has been shown to strengthen specific brain connections in people with psychosis. Now, researchers at King’s College London have found that these stronger connections are associated with a long-term reduction in symptoms and recovery even eight years later. CBT involves helping people change

Art Therapy as an Intervention for Psychosis

This post originally featured on the Psychiatry Advisor Expressive therapies are "complex interventions that combine psychotherapeutic techniques with activities aimed at promoting creative expression."1 The 2014 guidelines of the National Institute for Health and Clinical Excellence (NICE) on the Treatment of Psychosis and Schizophrenia in Adults recommend these modalities — including art

Mindfulness Intervention Effective for Distressing Voices in Psychosis

December 12, 2016 Share this content: Combined cognitive therapy and mindfulness can have lasting positive effects on behavior and mood. Group person-based cognitive therapy (PBCT), which integrates cognitive therapy with mindfulness, is effective in alleviating distress in individuals with psychosis who are hearing voices, according to a study conducted by a UK-based research

Underlying Mechanism of Auditory Impairment in Schizophrenia Reveals Potential Therapeutic Path

December 12, 2016 Share this content: Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading. Dysfunction in N-methyl-D-aspartate (NMDA) brain receptors appears to contribute to the deficits in cortical plasticity that cause patients with schizophrenia to struggle with distinguishing slight changes in auditory pitch, suggests a new

Prolactin-Related Symptoms Decrease with Reduced Risperidone Dosage

December 07, 2016 Share this content: Hyperprolactinemia should be monitored during long-term risperidone treatment. The severity of prolactin-related symptoms from risperidone treatment for schizophrenia decreased with a reduction in dosage, suggesting a need to track hyperprolactinemia during long-term risperidone treatment, according to a recent article in BMC Psychiatry. “Attention should focus on the side

Short-Term Suicide Risk For Discharged Psychiatric Hospital Patients

December 02, 2016 Share this content: Little is known about risk of suicide across multiple disorders or in general medical conditions with psychiatric comorbidities. Researchers have found that after being discharged from an inpatient psychiatric hospital, patients with depression were at a particularly high risk of short-term suicide. Those with schizophrenia or bipolar

Efficacy of Lurasidone Assessed in Adolescents With Schizophrenia

November 14, 2016 This article originally appeared on MPR. Share this content: Sunovion have announced positive results from a study evaluating Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years old. A double-blind, placebo-controlled six week study randomized 285 adolescents with schizophrenia to receive fixed doses of Latuda

Impaired Auditory 40-Hz Steady-State Responses Noted in Schizophrenia

November 11, 2016 Share this content: 40-Hz ASSR spectral power and phase-locking deficits could be useful probes for assessing circuit dysfunctions in the disorder. Individuals with schizophrenia have consistent impairments in 40-Hz auditory steady-state response (ASSR), according to a new meta-analysis published in JAMA Psychiatry.1 A team of researchers affiliated with the University of

Prediabetic Markers May Be Linked With First-Episode Psychosis

November 11, 2016 Share this content: The findings might help to explain the increased prevalence of type 2 diabetes in patients with schizophrenia. Prediabetic markers, particularly impaired glucose tolerance and insulin resistance, are potentially linked with first-episode psychosis, according to a systematic review and meta-analysis published in Lancet Psychiatry.1 A team of researchers based